Word

WUXIDAR4

Status

Dead

Status Code

606

Status Date

Monday, January 16, 2023

Serial Number

90182832

Mark Type

3000

Filing Date

Tuesday, September 15, 2020

Published for Opposition

Tuesday, April 20, 2021

Abandoned Date

Monday, January 16, 2023

Trademark Owner History

WuXi Biologics Co., Ltd. - Owner At Publication

Classifications

40 Biomanufacturing for others, namely, manufacturing of biopharmaceuticals using biological organisms in the manufacturing process; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Manufacturing services for others in the field of biopharmaceuticals

5 Pharmaceutical preparations for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Drugs for medical purposes, namely, anticancer drugs; Biological preparations for medical purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Medicines for human purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Biochemical medicines for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Antibody drug for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Multispecific antibody for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Multispecific antibody format for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Medicines for veterinary purposes for treatment of canine disease; Biological preparations for veterinary purposes for treatment of canine disease

42 Biomedical research services; Development of pharmaceutical preparations and medicines; Drug discovery services; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical research services; Product development for others; Product quality testing services; Product safety testing services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of new products for others; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

The mark consists of the stylized wording "WuXiDAR4" with the letters "WuXi" in black, the letter "D" in green the letter "A" in blue with legs extending to form the underline beneath the wording in turquoise, yellow, green, blue and yellow, and the letter "R" in turquoise, with the superscript number "4" in green.
WUXIDAR 4; WUXIDAR FOUR
The color(s) black, light green, blue, turquoise, green, and yellow is/are claimed as a feature of the mark.

Trademark Events

Jan 17, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 16, 2023

Abandonment - No Use Statement Filed

Jun 14, 2022

Notice Of Approval Of Extension Request E-Mailed

Jun 10, 2022

Sou Extension 2 Granted

Jun 10, 2022

Sou Extension 2 Filed

Jun 10, 2022

Teas Extension Received

Dec 16, 2021

Notice Of Approval Of Extension Request E-Mailed

Dec 14, 2021

Sou Extension 1 Granted

Dec 14, 2021

Sou Extension 1 Filed

Dec 14, 2021

Teas Extension Received

Jun 15, 2021

Noa E-Mailed - Sou Required From Applicant

Apr 20, 2021

Official Gazette Publication Confirmation E-Mailed

Apr 20, 2021

Published For Opposition

Mar 31, 2021

Notification Of Notice Of Publication E-Mailed

Mar 12, 2021

Approved For Pub - Principal Register

Feb 23, 2021

Teas/Email Correspondence Entered

Feb 23, 2021

Correspondence Received In Law Office

Feb 23, 2021

Teas Response To Office Action Received

Feb 5, 2021

Notification Of Non-Final Action E-Mailed

Feb 5, 2021

Non-Final Action E-Mailed

Feb 5, 2021

Non-Final Action Written

Jan 27, 2021

Assigned To Examiner

Oct 23, 2020

Notice Of Design Search Code E-Mailed

Oct 22, 2020

New Application Office Supplied Data Entered In Tram

Sep 18, 2020

New Application Entered In Tram